# Amrize Ltd (AMRZ) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Construction Materials. Price $43.82, market value $24.0 billion.

## Valuation
- **P/E (trailing): 19.7×** (5-yr avg 25.0×, 3-yr avg 25.0×). Amrize Ltd trades at 19.7× trailing earnings, well below its own five-year average of 25.0×: cheap by its own standards. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 14.6×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 2.0×**. Each dollar of revenue is priced at 2.0×.
- **Price / book: 1.9×**. The shares trade at 1.9× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 10.1×**. Enterprise value is 10.1× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 5.5%** (5-yr avg 4.8%). Free cash flow equals 5.5% of the market value, in line with its five-year average of 4.8%. Above 5% is generally attractive.
- **Earnings yield: 5.1%**. The inverse of the P/E: 5.1% of the price is earned each year.

## Profitability
- **Gross margin: 25.0%**. Amrize Ltd keeps 25.0% of revenue after the direct cost of what it sells.
- **Operating margin: 15.5%**. 15.5% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 10.0%**. 10.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 8.9%**. 8.9% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 9.0%**. Return on all capital, debt included, is 9.0%.
- **Return on assets: 5.0%**. Each dollar of assets produces 5.0% of profit.

## Growth
- **Revenue growth (1 yr): 0.9%**. Revenue grew 0.9% over the last year.
- **EPS growth (1 yr): -7.0%**. Earnings per share fell 7.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.40**. Debt is 0.40 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 1.2×**. It would take 1.2 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 2.82**. A Z-score of 2.82 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 0.95%** ($0.44 per share, trailing). Amrize Ltd yields 0.95%, a modest yield more typical of a growth-oriented payer.

## Analyst view
- **Analyst consensus: buy** (19 analysts). 19 analysts cover Amrize Ltd; the consensus is buy, with an average price target of $56.48 (+29% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -15.3%** (YTD -18.2%, 3-mo -18.2%). The shares are down 15.3% over twelve months including dividends.
- **From 52-week high: -33.5%** (5.3% above the low). Trading 34% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 40**. An RSI of 40 is neutral.
- **Beta (1 yr): 1.35** (volatility 37%). Beta of 1.35 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AMRZ · Page: https://foliofundamentals.com/stocks/amrz

Not investment advice.